Correction to: "Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial"
J Clin Endocrinol Metab
.
2025 Feb 4:dgaf048.
doi: 10.1210/clinem/dgaf048.
Online ahead of print.
PMID:
39903658
DOI:
10.1210/clinem/dgaf048
No abstract available
Publication types
Published Erratum